0001225208-14-017932.txt : 20140805
0001225208-14-017932.hdr.sgml : 20140805
20140805095642
ACCESSION NUMBER: 0001225208-14-017932
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140804
FILED AS OF DATE: 20140805
DATE AS OF CHANGE: 20140805
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Merck & Co. Inc.
CENTRAL INDEX KEY: 0000310158
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 221918501
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE MERCK DRIVE
STREET 2: P.O. BOX 100
CITY: WHITEHOUSE STATION
STATE: NJ
ZIP: 08889-0100
BUSINESS PHONE: 908-423-1000
MAIL ADDRESS:
STREET 1: ONE MERCK DRIVE
STREET 2: P.O. BOX 100
CITY: WHITEHOUSE STATION
STATE: NJ
ZIP: 08889-0100
FORMER COMPANY:
FORMER CONFORMED NAME: SCHERING PLOUGH CORP
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: AMBROSE ADELE D
CENTRAL INDEX KEY: 0001182424
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-06571
FILM NUMBER: 141014872
MAIL ADDRESS:
STREET 1: 7277 164TH AVE NE
STREET 2: BLDG 1
CITY: REDMOND
STATE: WA
ZIP: 98052
4
1
doc4.xml
X0306
4
2014-08-04
0000310158
Merck & Co. Inc.
MRK
0001182424
AMBROSE ADELE D
ONE MERCK DRIVE
WHITEHOUSE STATION
NJ
08889-0100
1
Sr.V-P & Chief Comuns Officer
Common Stock
2014-08-04
4
M
0
15000.0000
45.9800
A
34443.9080
D
Common Stock
2014-08-04
4
M
0
8400.0000
44.3000
A
42843.9080
D
Common Stock
2014-08-04
4
S
0
28669.0000
56.6368
D
14174.9080
D
Stock Option (right to buy)
45.9800
2014-08-04
4
M
0
15000.0000
0.0000
D
2009-02-01
2018-01-31
Common Stock
15000.0000
0.0000
D
Stock Option (right to buy)
44.3000
2014-08-04
4
M
0
8400.0000
0.0000
D
2009-02-28
2018-02-28
Common Stock
8400.0000
0.0000
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.5800 to $56.7100, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.
Holdings include shares acquired in dividend reinvestment transactions.
The option became exercisable in equal installments on 2/1/2009, 2/1/2010 and 2/1/2011.
The option became exercisable in equal installments on 2/28/2009, 2/28/2010 and 2/28/2011.
Katie Fedosz as Attorney-in-Fact for Adele D. Ambrose
2014-08-05